The Canberra Times |
Nurse Kerri Cargill’s wait for life-saving organ donor reveals patchwork of …
The Canberra Times The Organ and Tissue Authority says less than 1 per cent of people die in intensive care units or emergency departments in the specific circumstances required to be a potential organ donor. It says it is vital that potential donor families realise that … |
New Drug Combo Potentially 'Practice Changing' in CLL – Medscape
|
New Drug Combo Potentially ‘Practice Changing’ in CLL
Medscape NEW ORLEANS — More clinical details have been reported showing how the new monoclonal antibody obinutuzumab (Gazvya, Roche) was superior to the stadard therapy rituximab (Rituxan, Roche) when both were used in combination with chlorambucil in … |
Gilead Announces Pivotal Phase 2 Data for Idelalisib in Refractory Indolent … – Business Wire (press release)
Gilead Announces Pivotal Phase 2 Data for Idelalisib in Refractory Indolent …Business Wire (press release)Study 101-09 is a Phase 2, open-label, single-arm efficacy and safety study of idelalisib in patients with previously treated iNHL that is refra…
HIV returns in 2 thought cured after stem cell transplant – The Columbian
NPRHIV returns in 2 thought cured after stem cell transplantThe ColumbianGENEVA – Two HIV-infected men who were thought to be clear of the virus after having stem cell transplants have had the AIDS-causing pathogen return, their doctors said, dashing h…
Dr. Goede on Obinutuzumab Versus Rituximab in CLL – OncLive
WalesOnline |
Dr. Goede on Obinutuzumab Versus Rituximab in CLL
OncLive Valentin Goede, MD, from the University Hospital Cologne and the German CLL Study Group, discusses the efficacy findings from the stage 2 CLL11 study that examined obinutuzumab (Gazyva; formally GA101) plus chlorambucil in patients with chronic … New Drug Combo Potentially ‘Practice Changing’ in CLLMedscape Improved Efficacy, Limited Toxicity of Targeted Therapies Brighten the Future …SYS-CON Media (press release) ‘Exciting’ leukaemia drug trial results published after Welsh hospital trialsWalesOnline |
Excitement Over CAR-Engineered T-cells in Leukemia and Lymphoma – Medscape
|
Excitement Over CAR-Engineered T-cells in Leukemia and Lymphoma
Medscape This was a patient who had undergone 10 prior therapies, including many different combinations of rituximab plus chemotherapy regimens, and the disease progressed a month after chemotherapy finished, so she was “clearly refractory,” he said. “Our data … Treated T-cells induce remissions in chemo-refractory B-cell lymphomasThe Oncology Report |
Tracking your heart while you pound the road – Times of India
|
Tracking your heart while you pound the road
Times of India “This is the first of its kind not only in India but in the world. It is already out in the market. The device is attached to the athlete’s body. We are going to work on a sports module for the same machine that is attached to the body now. It will be … |
HIV returns in 2 thought cured after stem cell transplant – Chicago Tribune
The Nation |
HIV returns in 2 thought cured after stem cell transplant
Chicago Tribune HIV returns in 2 thought cured after stem cell transplant. print. By Simeon Bennett, Bloomberg News Bloomberg. 11:20 p.m. CST, December 8, 2013. GENEVA — Two HIV-infected men who were thought to be clear of the virus after having stem cell transplants … HIV Returns in Two Men Thought Cured After Stem Cell TransplantBusinessweek HIV returns in two patients after bone marrow transplantksl.com |
Buddha the inspirational internet fat cat dies of heart failure aged six – Mirror.co.uk
Mirror.co.ukBuddha the inspirational internet fat cat dies of heart failure aged sixMirror.co.ukAn obese cat who became an inspirational online sensation after video of his weight loss regime – which included workouts on an underwater treadmill – went …
Age barrier falls for half-matched bone marrow transplants – The Oncology Report
Age barrier falls for half-matched bone marrow transplantsThe Oncology ReportNo prior autologous BMT was allowed and post-BMT rituximab (Rituxan) was used in 55 of 126 patients with B-cell lymphoma. Patients in their 50s, 60s, and 70s had similar estim…